3-(2,4-dimethoxybenzylidene)anabaseine and 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole

3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole in 3 studies

Compound Research Comparison

Studies (3-(2,4-dimethoxybenzylidene)anabaseine)	Trials (3-(2,4-dimethoxybenzylidene)anabaseine)	Recent Studies (post-2010) (3-(2,4-dimethoxybenzylidene)anabaseine)	Studies (3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole)	Trials (3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole)	Recent Studies (post-2010) (3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole)
166	8	81	68	2	18

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dart, MJ; Holladay, MW; Lynch, JK	1
Anderson, DJ; Arneric, SP; Bannon, AW; Briggs, CA; Brioni, JD; Decker, MW; Donnelly-Roberts, D; Holladay, MW; Sullivan, JP; Williams, M	1
Briggs, CA; McKenna, DG; Piattoni-Kaplan, M	1

Reviews

2 review(s) available for 3-(2,4-dimethoxybenzylidene)anabaseine and 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole

Article	Year
Neuronal nicotinic acetylcholine receptors as targets for drug discovery. Journal of medicinal chemistry, 1997, Dec-19, Volume: 40, Issue:26 Topics: Acetylcholine; Animals; Binding Sites; Dopamine; Drug Design; Humans; Molecular Structure; Nervous System; Neurons; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Nicotinic; Structure-Activity Relationship	1997
Cholinergic channel activators: novel opportunities for the treatment of CNS disorders. Proceedings of the Western Pharmacology Society, 1995, Volume: 38 Topics: Animals; Anti-Anxiety Agents; Benzylidene Compounds; Bridged Bicyclo Compounds, Heterocyclic; Central Nervous System Diseases; Cholinergic Antagonists; Humans; Ion Channels; Isoxazoles; Nicotinic Agonists; Parasympathetic Nervous System; Pyridines; Pyrrolidines; Receptors, Cholinergic	1995

Article

Year

Neuronal nicotinic acetylcholine receptors as targets for drug discovery.

Journal of medicinal chemistry, 1997, Dec-19, Volume: 40, Issue:26

Topics: Acetylcholine; Animals; Binding Sites; Dopamine; Drug Design; Humans; Molecular Structure; Nervous System; Neurons; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Nicotinic; Structure-Activity Relationship

1997

Cholinergic channel activators: novel opportunities for the treatment of CNS disorders.

Proceedings of the Western Pharmacology Society, 1995, Volume: 38

Topics: Animals; Anti-Anxiety Agents; Benzylidene Compounds; Bridged Bicyclo Compounds, Heterocyclic; Central Nervous System Diseases; Cholinergic Antagonists; Humans; Ion Channels; Isoxazoles; Nicotinic Agonists; Parasympathetic Nervous System; Pyridines; Pyrrolidines; Receptors, Cholinergic

1995

Other Studies

1 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole

Article	Year
Human alpha 7 nicotinic acetylcholine receptor responses to novel ligands. Neuropharmacology, 1995, Volume: 34, Issue:6 Topics: Anti-Anxiety Agents; Barium; Benzylidene Compounds; Binding, Competitive; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Chloride Channels; Dose-Response Relationship, Drug; Humans; Isoxazoles; Ligands; Membrane Potentials; Nicotinic Agonists; Oocytes; Patch-Clamp Techniques; Pyridines; Pyrrolidines; Receptors, Nicotinic; RNA, Messenger	1995

Article

Year

Human alpha 7 nicotinic acetylcholine receptor responses to novel ligands.

Neuropharmacology, 1995, Volume: 34, Issue:6

Topics: Anti-Anxiety Agents; Barium; Benzylidene Compounds; Binding, Competitive; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Chloride Channels; Dose-Response Relationship, Drug; Humans; Isoxazoles; Ligands; Membrane Potentials; Nicotinic Agonists; Oocytes; Patch-Clamp Techniques; Pyridines; Pyrrolidines; Receptors, Nicotinic; RNA, Messenger

1995